Taiyen Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Taiyen Biotech has a total shareholder equity of NT$6.6B and total debt of NT$194.8M, which brings its debt-to-equity ratio to 3%. Its total assets and total liabilities are NT$8.2B and NT$1.7B respectively. Taiyen Biotech's EBIT is NT$315.5M making its interest coverage ratio -9.5. It has cash and short-term investments of NT$1.7B.
Key information
3.0%
Debt to equity ratio
NT$194.84m
Debt
| Interest coverage ratio | -9.5x |
| Cash | NT$1.74b |
| Equity | NT$6.55b |
| Total liabilities | NT$1.68b |
| Total assets | NT$8.23b |
Recent financial health updates
Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet
Apr 24
Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly
Jan 17
Recent updates
Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20
Jul 31Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality
May 09Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet
Apr 24Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher
Apr 09A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)
Mar 25Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?
Mar 12Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?
Feb 14Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend
Feb 01Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)
Jan 04A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)
Dec 22How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?
Dec 09Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return
Nov 24Financial Position Analysis
Short Term Liabilities: 1737's short term assets (NT$2.8B) exceed its short term liabilities (NT$1.0B).
Long Term Liabilities: 1737's short term assets (NT$2.8B) exceed its long term liabilities (NT$653.6M).
Debt to Equity History and Analysis
Debt Level: 1737 has more cash than its total debt.
Reducing Debt: 1737's debt to equity ratio has increased from 0.3% to 3% over the past 5 years.
Debt Coverage: 1737's debt is well covered by operating cash flow (272.4%).
Interest Coverage: 1737 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 21:59 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Taiyen Biotech Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | E.Sun Securities Investment Consulting Co. Ltd. |
| Titan Horng | IBTS Investment Consulting Co., Ltd. |
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |